Drugs that regulate local cell signaling: AKAP targeting as a therapeutic option

PJ Bucko, JD Scott - Annual review of pharmacology and …, 2021 - annualreviews.org
Cells respond to environmental cues by mobilizing signal transduction cascades that
engage protein kinases and phosphoprotein phosphatases. Correct organization of these …

Microtubule‐binding proteins as promising biomarkers of paclitaxel sensitivity in cancer chemotherapy

S Xie, A Ogden, R Aneja, J Zhou - Medicinal research reviews, 2016 - Wiley Online Library
Microtubules, tirelessly animated and highly dynamic structures, are vital for most cellular
processes and their intricacies are still being revealed even after a century since their …

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

M Giordano, A Decio, C Battistini, M Baronio… - Journal of Experimental …, 2021 - Springer
Background Cancer stem cells (CSC) have been implicated in tumor progression. In ovarian
carcinoma (OC), CSC drive tumor formation, dissemination and recurrence, as well as drug …

Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

NW Bateman, T Abulez, AR Soltis, A McPherson… - NPJ precision …, 2024 - nature.com
We performed a deep proteogenomic analysis of bulk tumor and laser microdissection
enriched tumor cell populations from high-grade serous ovarian cancer (HGSOC) tissue …

Identification of hypoxia signature to assess the tumor immune microenvironment and predict prognosis in patients with ovarian cancer

C Wei, X Liu, Q Wang, Q Li, M Xie - International journal of …, 2021 - Wiley Online Library
Background. The 5‐year overall survival rate of ovarian cancer (OC) patients is less than
40%. Hypoxia promotes the proliferation of OC cells and leads to the decline of cell …

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens

AL Hunt, NW Bateman, W Barakat, S Makohon-Moore… - Iscience, 2021 - cell.com
Enriched tumor epithelium, tumor-associated stroma, and whole tissue were collected by
laser microdissection from thin sections across spatially separated levels of ten high-grade …

TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach

T Cheraghi-Shavi, R Jalal, Z Minuchehr - PLoS One, 2023 - journals.plos.org
Acquired resistance to oxaliplatin is considered as the primary reason for failure in colorectal
cancer (CRC) therapy. Identifying the underlying resistance mechanisms may improve CRC …

Pan-cancer analysis of the prognosis and immunological role of AKAP12: a potential biomarker for resistance to anti-VEGF inhibitors

Q Liang, J Peng, Z Xu, Z Li, F Jiang, L Ouyang… - Frontiers in …, 2022 - frontiersin.org
The primary or acquired resistance to anti-VEGF inhibitors remains a common problem in
cancer treatment. Therefore, identifying potential biomarkers enables a better understanding …

LSD1 and CoREST2 Potentiate STAT3 Activity to Promote Enteroendocrine Cell Differentiation in Mucinous Colorectal Cancer

CA Ladaika, AH Ghobashi, WC Boulton… - Cancer …, 2025 - aacrjournals.org
Neuroendocrine cells have been implicated in therapeutic resistance and worse overall
survival in many cancer types. Mucinous colorectal cancer (mCRC) is uniquely enriched for …

Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells

VO Shender, KS Anufrieva, PV Shnaider… - Nature …, 2024 - nature.com
Ovarian cancer often develops resistance to conventional therapies, hampering their
effectiveness. Here, using ex vivo paired ovarian cancer ascites obtained before and after …